Discarded Drug Refunds in Medicare Part B: What Drug Manufacturers, Providers and Payers Need to Know

Register: http://www.pharmaceuticalcommerce.com/pc_w/discarded

Event Overview:

Beginning January 1, 2023, drug manufacturers will be required to refund Medicare the portion of a single dose container or single-use package that was discarded. This webinar will take a look at the history of this proposal, explain the provisions and requirements of the new statute, and explore the operational impacts to manufacturers, providers and payers. Operationalizing program changes like this one can cause friction and challenges, but with the right preparation and a smart, data-driven approach, stakeholders can be confidently prepared to participate transparently, compliantly and effectively.

Key Learning Objectives:

• Contextualize the events leading to the passage of the discarded drug refund program
• Understand the provisions and requirements of the statute
• Anticipate challenges and friction that will likely arise between drug manufacturers, providers and payers when implementing the discarded drug refund program
• Envision how ubiquitous data platform can reduce stakeholder friction and improve compliance by transparently connecting manufacturers, payers and providers

Who Should Attend:

• Executives, Senior Leaders, Vice Presidents, Directors and Managers
• Drug Manufacturers, Health Care Providers, and Payers

Speakers

Jeremy Docken
Chief Strategy Officer and Founder
Kalderos

Jeremy has exhaustive expertise in drug compliance trends and policy from nearly a decade as a consultant to life science and pharmaceutical manufacturers. Driven by witnessing long standing problems in the drug discount space, Jeremy led the founding of Kalderos in 2016. His passion is solving systemic problems of the healthcare system.

Trevor Wear
Partner
Sidley Austin LLP

Trevor is a partner in the global law firm of Sidley Austin LLP. His practice focuses primarily on healthcare regulatory and compliance matters, including Medicare and Medicaid reimbursement and coverage, Stark and Anti-Kickback law and False Claims Act analyses, government price reporting for pharmaceutical products, compliance program counseling, and healthcare and managed care contracting. Trevor advises a variety of clients on these matters, including pharmaceutical and medical device manufacturers, clinical laboratories, healthcare consulting companies, durable medical equipment suppliers, diagnostic imaging providers, physician practices, and medical associations and societies.

Leveraging over thirteen years of experience in healthcare administration and law, Trevor’s practice covers much of the healthcare industry, although he devotes much of his time to counseling pharmaceutical and medical device manufacturers on coverage and reimbursement issues and fraud and abuse and other compliance matters both in the U.S. and abroad.

In a joint four-year program, Trevor received his J.D., cum laude, Order of the Woolsack, from Saint Louis University School of Law, where he was the Editor-in-Chief for the Journal of Health Law, and his M.H.A., highest distinction, from Saint Louis University School of Public Health in 2005. Trevor received my B.S., summa cum laude, in Health Information Management from Saint Louis University in 2001. While completing his studies, Trevor performed extensive legal and administrative internships with two of the nation’s largest healthcare entities.

With more than 1,800 lawyers in 19 offices worldwide, Sidley has built a reputation as a premier legal adviser for global businesses and financial institutions. For the fourth consecutive year, and every year since the survey’s inception, Sidley received the most first-tier national rankings of any U.S. law firm in the 2014 U.S. News – Best Lawyers® “Best Law Firms” survey.

Register http://www.pharmaceuticalcommerce.com/pc_w/discarded